List of Contents

Medical Radiation Detection Market Size, Share, and Trends 2024 to 2034

Medical Radiation Detection Market (By Type: Gas-Filled Detectors, Scintilators, Solid-State; By Product: Personal Dosimeters, Area Process Dosimeters, Surface Contamination Monitors, Others; By End Use: Hospitals, Ambulatory Surgical Centers, Diagnostic Imaging Centers, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032

  • Last Updated : July 2024
  • Report Code : 3389
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Medical Radiation Detection Market 

5.1. COVID-19 Landscape: Medical Radiation Detection Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Medical Radiation Detection Market, By Type

8.1. Medical Radiation Detection Market, by Type, 2024-2034

8.1.1 Gas-Filled Detectors

8.1.1.1. Market Revenue and Forecast (2021-2034)

8.1.2. Scintilators

8.1.2.1. Market Revenue and Forecast (2021-2034)

8.1.3. Solid-State

8.1.3.1. Market Revenue and Forecast (2021-2034)

Chapter 9. Global Medical Radiation Detection Market, By Product

9.1. Medical Radiation Detection Market, by Product, 2024-2034

9.1.1. Personal Dosimeters

9.1.1.1. Market Revenue and Forecast (2021-2034)

9.1.2. Area Process Dosimeters

9.1.2.1. Market Revenue and Forecast (2021-2034)

9.1.3. Surface Contamination Monitors

9.1.3.1. Market Revenue and Forecast (2021-2034)

9.1.4. Others

9.1.4.1. Market Revenue and Forecast (2021-2034)

Chapter 10. Global Medical Radiation Detection Market, By End Use 

10.1. Medical Radiation Detection Market, by End Use, 2024-2034

10.1.1. Hospitals

10.1.1.1. Market Revenue and Forecast (2021-2034)

10.1.2. Ambulatory Surgical Centers

10.1.2.1. Market Revenue and Forecast (2021-2034)

10.1.3. Diagnostic Imaging Centers

10.1.3.1. Market Revenue and Forecast (2021-2034)

10.1.4. Others

10.1.4.1. Market Revenue and Forecast (2021-2034)

Chapter 11. Global Medical Radiation Detection Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Type (2021-2034)

11.1.2. Market Revenue and Forecast, by Product (2021-2034)

11.1.3. Market Revenue and Forecast, by End Use (2021-2034)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Type (2021-2034)

11.1.4.2. Market Revenue and Forecast, by Product (2021-2034)

11.1.4.3. Market Revenue and Forecast, by End Use (2021-2034)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Type (2021-2034)

11.1.5.2. Market Revenue and Forecast, by Product (2021-2034)

11.1.5.3. Market Revenue and Forecast, by End Use (2021-2034)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Type (2021-2034)

11.2.2. Market Revenue and Forecast, by Product (2021-2034)

11.2.3. Market Revenue and Forecast, by End Use (2021-2034)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Type (2021-2034)

11.2.4.2. Market Revenue and Forecast, by Product (2021-2034)

11.2.4.3. Market Revenue and Forecast, by End Use (2021-2034)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Type (2021-2034)

11.2.5.2. Market Revenue and Forecast, by Product (2021-2034)

11.2.5.3. Market Revenue and Forecast, by End Use (2021-2034)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Type (2021-2034)

11.2.6.2. Market Revenue and Forecast, by Product (2021-2034)

11.2.6.3. Market Revenue and Forecast, by End Use (2021-2034)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Type (2021-2034)

11.2.7.2. Market Revenue and Forecast, by Product (2021-2034)

11.2.7.3. Market Revenue and Forecast, by End Use (2021-2034)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Type (2021-2034)

11.3.2. Market Revenue and Forecast, by Product (2021-2034)

11.3.3. Market Revenue and Forecast, by End Use (2021-2034)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Type (2021-2034)

11.3.4.2. Market Revenue and Forecast, by Product (2021-2034)

11.3.4.3. Market Revenue and Forecast, by End Use (2021-2034)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Type (2021-2034)

11.3.5.2. Market Revenue and Forecast, by Product (2021-2034)

11.3.5.3. Market Revenue and Forecast, by End Use (2021-2034)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Type (2021-2034)

11.3.6.2. Market Revenue and Forecast, by Product (2021-2034)

11.3.6.3. Market Revenue and Forecast, by End Use (2021-2034)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Type (2021-2034)

11.3.7.2. Market Revenue and Forecast, by Product (2021-2034)

11.3.7.3. Market Revenue and Forecast, by End Use (2021-2034)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Type (2021-2034)

11.4.2. Market Revenue and Forecast, by Product (2021-2034)

11.4.3. Market Revenue and Forecast, by End Use (2021-2034)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Type (2021-2034)

11.4.4.2. Market Revenue and Forecast, by Product (2021-2034)

11.4.4.3. Market Revenue and Forecast, by End Use (2021-2034)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Type (2021-2034)

11.4.5.2. Market Revenue and Forecast, by Product (2021-2034)

11.4.5.3. Market Revenue and Forecast, by End Use (2021-2034)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Type (2021-2034)

11.4.6.2. Market Revenue and Forecast, by Product (2021-2034)

11.4.6.3. Market Revenue and Forecast, by End Use (2021-2034)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Type (2021-2034)

11.4.7.2. Market Revenue and Forecast, by Product (2021-2034)

11.4.7.3. Market Revenue and Forecast, by End Use (2021-2034)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Type (2021-2034)

11.5.2. Market Revenue and Forecast, by Product (2021-2034)

11.5.3. Market Revenue and Forecast, by End Use (2021-2034)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Type (2021-2034)

11.5.4.2. Market Revenue and Forecast, by Product (2021-2034)

11.5.4.3. Market Revenue and Forecast, by End Use (2021-2034)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Type (2021-2034)

11.5.5.2. Market Revenue and Forecast, by Product (2021-2034)

11.5.5.3. Market Revenue and Forecast, by End Use (2021-2034)

Chapter 12. Company Profiles

12.1. Thermo Fisher Scientific, Inc.

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. UAB Polimaster Europe

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. PTW Freiburg GmbH

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. ATOMTEX

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Sanlar imex services private limited

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. LANDAUER

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Mirion Technologies, Inc

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. MP BIOMEDICALS.

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. SIERRA RADIATION DOSIMETRY SERVICE, INC.

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. IBA Dosimetry GmbH

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

 

14.2. Glossary of Terms

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client